IDXX Q2 2021 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q2 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$826M+29.6% YoY

Gross Profit

$489M59.2% margin

Operating Income

$259M31.4% margin

Net Income

$203M24.5% margin

EPS (Diluted)

$2.34

QoQ Revenue Growth

+6.2%

Cash Flow

Operating Cash Flow

$234M

Free Cash Flow

$211M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.7B

Stockholders' Equity

$747M

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$826M	$638M	+29.6%
Gross Profit	$489M	$379M	+29.0%
Operating Income	$259M	$193M	+34.2%
Net Income	$203M	$149M	+36.0%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$2.5B98%

Reagent Rental Programs

$38M1%

Extended Warranties And Post Contract Support

$19M1%

Instrument Rebate Programs

$4M0%

Geographic Segments

UNITED STATES

$515M62%

EMEA

$172M21%

Asia Pacific

$84M10%

CANADA

$39M5%

Latin America

$16M2%